Global Digital Pathology Market Size to Hit USD 2.92 Billion by 2032, Growing at 12.54% CAGR – SNS Insider
Digital Pathology Market Growth is Driven by Advancements in AI, Remote Healthcare Solutions and Demand for Accurate Diagnostics and Automation.
Pune, Feb. 04, 2025 (GLOBE NEWSWIRE) — Global Digital Pathology Market Size & Growth Analysis:
According to SNS Insider, The Global Digital Pathology Market size was valued USD 1.01 billion in 2023 and projected to grow at a CAGR of 12.54% to reach USD 2.92 billion by 2032. This remarkable growth is attributed to the increasing adoption of digital imaging systems in pathology, advancements in artificial intelligence for diagnosis, and the growing demand for automation in healthcare settings. Additionally, the ongoing trend toward remote healthcare services and the need for faster and more accurate diagnostic processes are pushing the demand for digital pathology solutions.
The digital pathology market is also benefiting from the rising prevalence of chronic diseases, such as cancer, and the subsequent need for more efficient, scalable, and accurate diagnostic tools. As healthcare providers move toward digital solutions, the integration of AI and machine learning in pathology workflows is expected to be a key driver of growth in this market.
Get a Sample Report of Digital Pathology Market@ https://www.snsinsider.com/sample-request/1763
Market Trends:
- Growing demand for AI-powered diagnostic tools.
- Increased integration of cloud storage and data sharing capabilities.
- Rising adoption of digital pathology in drug discovery and development.
- Enhanced operational efficiency through automation and AI integration.
The Digital Pathology Market is experiencing rapid growth, driven by the increasing demand for high-quality diagnostic solutions in healthcare settings.
Digital pathology enables pathologists to digitally capture, store, and analyze high-resolution images of tissue samples, providing better accuracy and efficiency in diagnostics. The shift from traditional microscopy to digital imaging is transforming the pathology landscape, allowing for remote consultations, faster diagnostics, and improved patient outcomes.
The demand for digital pathology is being fueled by the growing need for precise cancer diagnoses, drug discovery applications, and disease management. Additionally, as the healthcare industry increasingly embraces digitalization, the integration of advanced technologies such as AI, cloud storage, and automation is making digital pathology solutions indispensable for modern healthcare practices. The market is also benefiting from the need for large-scale data storage solutions due to the massive amounts of data generated by high-resolution imaging technologies.
Key Digital Pathology Market Companies Profiled
- Fujifilm Holdings Corporation
- Danaher Corporation
- Koninklijke Philips N.V.
- Mikroscan Technologies Inc.
- PathAI
- Hamamatsu Photonics K.K.
- F. Hoffmann-La Roche Ltd.
- 3DHISTECH
- Apollo Enterprise Imaging
- XIFIN Inc.
- Proscia Inc.
- KONFOONG BIOTECH INTERNATIONAL
- Sectra AB
- Leica Biosystems Nussloch GmbH (Danaher)
- Olympus Corporation
- Inspirata Inc.
- Epredia (3DHISTECH Ltd.)
- Visiopharm A/S
- Huron Technologies International Inc.
- ContextVision AB
- CellaVision
- HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO)
- West Medica Produktions- und Handels-GmbH (West Medica)
- aetherAI
- IBEX (IBEX MEDICAL ANALYTICS)
- SigTuple Technologies Private Limited
- Morphle Labs Inc.
- Bionovation Biotech Inc.
Digital Pathology Market Report Scope
| Report Attributes | Details |
| Market Size in 2023 | US$ 1.01 billion |
| Market Size by 2032 | US$ 2.92 billion |
| CAGR | CAGR of 12.54% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Key Regional Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East]), Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Key Growth Drivers | AI-driven automation, increased remote diagnostics, and rising demand for precision medicine. |
Segmentation Analysis
By Product:
In 2023, the Software segment dominated the Digital Pathology Market, accounting for 45% of the market share. The demand for advanced image analysis and management software is rapidly growing, especially with the integration of AI and machine learning algorithms that facilitate more accurate diagnoses and efficient workflows. These software solutions are used for analyzing and processing digital images, enabling pathologists to quickly interpret large volumes of data. As healthcare systems shift toward automation and AI-enhanced diagnostics, the software segment continues to experience strong growth.
The Storage Systems segment, particularly cloud-based storage, is emerging as the fastest-growing segment in the market. As the volume of digital data generated by pathology systems increases, the demand for scalable and secure storage solutions is surging. Cloud storage solutions offer benefits like remote access, secure data sharing, and seamless integration with digital pathology systems, making them essential in managing large datasets.
By Application:
In 2023, Drug Discovery & Development led the market, representing 55% of the share. Digital pathology plays a pivotal role in drug discovery by enabling high-resolution tissue imaging, biomarker identification, and the evaluation of therapeutic efficacy. This application is particularly valuable in the pharmaceutical and biotechnology sectors, where accelerated research timelines and reduced costs are essential.
The Disease Diagnosis segment is anticipated to have the fastest growth throughout the forecast period. The increasing prevalence of chronic diseases like cancer, combined with advancements in diagnostic technologies, has led to increased demand for digital pathology systems in clinical diagnostics. AI-powered tools further enhance diagnostic accuracy, allowing for quicker diagnoses and enabling remote consultations between medical professionals.
For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ https://www.snsinsider.com/request-analyst/1763
Digital Pathology Market Segmentation
By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
By Application
- Drug Discovery & Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
North America held the largest share of the Digital Pathology Market, accounting for over 40% of the global market.
This dominance is driven by the region’s advanced healthcare infrastructure, high adoption rates of digital pathology solutions, and strong research and development investments. The U.S. remains a major contributor, with significant investments from key industry players like Roche and Philips. The increasing prevalence of cancer and chronic diseases, along with the growing demand for telemedicine and remote diagnostics, further fuels market growth in North America.
The Asia Pacific region is projected to have the highest rate of growth during the forecast period. The increasing adoption of digital pathology in hospitals and diagnostic labs, particularly in China and India, is contributing to the market’s rapid expansion. Additionally, the rising incidence of cancer and other chronic diseases, coupled with government initiatives to modernize healthcare infrastructure, is supporting market growth in the region.
Recent Developments
- OptraSCAN raised USD 30 million in Series B funding in December 2024 to expand its mission of democratizing digital pathology and improving diagnostic accuracy worldwide.
- Central Maine Healthcare (CMH) partnered with Spectrum Healthcare Partners (SHCP) in October 2024 to enhance pathology services by adopting AI-enabled autonomous scanners from Pramana.
- In September 2024, Roche expanded its digital pathology open environment by integrating over 20 advanced AI algorithms from eight new collaborators to improve cancer diagnostics.
- PathAI and Labcorp Drug Development announced a collaboration in August 2024 to accelerate drug development and improve diagnostic accuracy using AI-based digital pathology tools.
Buy a Single-User PDF of Digital Pathology Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/1763
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
5.1 Adoption Rates and Penetration (2023)
5.2 Workflow Digitization Trends (2023), by Region
5.3 System Installations and Usage, by Region (2020-2032)
5.4 Healthcare IT Spending on Digital Pathology, by Region (Government, Commercial, Private, Out-of-Pocket), 2023
5.5 Research and Diagnostic Usage Statistics (2023)
5.6 Artificial Intelligence (AI) Integration Metrics (2023)
5.7 Image Data Volume Growth, by Region (2020–2032)
6. Competitive Landscape
7. Digital Pathology Market by Product
8. Digital Pathology Market by Application
9. Digital Pathology Market by End-use
10. Regional Analysis
11. Company Profiles
12. Use Cases and Best Practices
13. Conclusion
Access Complete Report Details of Digital Pathology Market Analysis & Outlook 2024-2032@ https://www.snsinsider.com/reports/digital-pathology-market-1763
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.